Pharmacy World & Science

, Volume 30, Issue 6, pp 892–897 | Cite as

Exploring patients’ perspectives of pharmacist supplementary prescribing in Scotland

  • Derek C. StewartEmail author
  • Johnson George
  • Christine M. Bond
  • I. T. Scott Cunningham
  • H. Lesley Diack
  • Dorothy J. McCaig
Research Article


Aim The aim of this study was to explore patients’ perspectives and experiences of pharmacist supplementary prescribing (SP) in Scotland. Method A survey in primary and secondary care in Scotland. Pharmacist supplementary prescribers (n = 10) were purposively selected across Scotland. All pharmacists distributed questionnaires to 20 consecutive patients as they attended appointments during October to December 2006. Reminders were mailed to all 20 patients by each pharmacist 2 weeks after initial distribution. Main outcome measures The questionnaire contained items on: attitudes towards pharmacist SP derived from earlier qualitative research; consultation satisfaction derived from a validated scale developed initially for general practitioners, with the term ‘doctor’ being replaced by ‘pharmacist prescriber’; and demographics. Closed and Likert scales were used as response options. Results One pharmacist withdrew. The patient response rate was 57.2% (103/180). The median age was 67 years (interquartile range 56.5–73 years), with 53.4% being female. Most (76, 73.8%) consulted with the pharmacist in a general practice setting. Patients reported positive consultation experiences with 89.3% agreeing/strongly agreeing that they were satisfied with the consultation, 78.7% thought the pharmacist told them everything about their treatment and 72.9% felt the pharmacist was interested in them as a person. Most patients were positive in their attitudes, agreeing that they would recommend a pharmacist prescriber to others and that they had trust in the pharmacist. However, 65% would prefer to consult a doctor. Conclusion Most patient respondents were satisfied with, and had a positive attitude towards, pharmacist prescribing consultations. However, most patients would still elect to see a doctor given the choice.


Pharmacist prescribing Supplementary prescribing Patient satisfaction Patient views Scotland 



We acknowledge support from the participating pharmacists and their patients, and A Bowbyes (for excellent administrative support).


This research was funded by NHS Education for Scotland (Pharmacy).

Conflicts of Interest



  1. 1.
    Avery AJ, Pringle M. Extended prescribing by UK nurses and pharmacists. BMJ. 2005;331:1154–5. doi: 10.1136/bmj.331.7526.1154.PubMedCrossRefGoogle Scholar
  2. 2.
    Department of Health. Improving patients’ access to medicines: a guide to implementing nurse and pharmacist independent prescribing within the NHS in England. London: Department of Health; 2006.Google Scholar
  3. 3.
    George J, McCaig D, Bond C, Cunningham ITS, Diack HL, Watson AM, et al. Supplementary prescribing: early experiences of pharmacists in Great Britain. Ann Pharmacother. 2006;40:1843–50. doi: 10.1345/aph.1H227.PubMedCrossRefGoogle Scholar
  4. 4.
    Hobson RJ, Sewell GJ. Supplementary prescribing by pharmacists in England. Am J Health Syst Pharm. 2006;63(3):244–53. doi: 10.2146/ajhp050178.PubMedCrossRefGoogle Scholar
  5. 5.
    Hobson RJ, Sewell GJ. Risks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists. Pharm World Sci. 2006;28(2):76–90. doi: 10.1007/s11096-006-9004-z.PubMedCrossRefGoogle Scholar
  6. 6.
    George J, McCaig D, Bond CM, Cunningham ITS, Diack HL, Stewart DC. Benefits and challenges of prescribing training and implementation: perceptions and early experiences of RPSGB prescribers. Int J Pharm Pract. 2007;15:23–30. doi: 10.1211/ijpp.15.1.0005.CrossRefGoogle Scholar
  7. 7.
    Lloyd F, Hughes C. Pharmacists’ and mentors’ views on the introduction of pharmacist supplementary prescribing: a qualitative evaluation of views and context. Int J Pharm Pract. 2005;15:31–7. doi: 10.1211/ijpp.15.1.0006.CrossRefGoogle Scholar
  8. 8.
    Smalley L. Patients’ experience of pharmacist-led supplementary prescribing in primary care. Pharm J. 2006;276:567–9.Google Scholar
  9. 9.
    Reid F, Murray P, Storrie M. Implementation of a pharmacist-led clinic for hypertensive patients in primary care—a pilot study. Pharm World Sci. 2005;27(3):202–7. doi: 10.1007/s11096-004-2563-y.PubMedCrossRefGoogle Scholar
  10. 10.
    McCann TV, Clark E. Attitudes of patients towards mental health nurse prescribing of antipsychotic agents. Int J Nurs Pract. 2008;14(2):115–21. doi: 10.1111/j.1440-172X.2008.00674.x.PubMedCrossRefGoogle Scholar
  11. 11.
    Department of Health. Creating a patient-led NHS: delivering the NHS improvement plan. NHS Crown Copyright; 2005.Google Scholar
  12. 12.
    Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe C. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001;323:1–5. doi: 10.1136/bmj.323.7325.1340.CrossRefGoogle Scholar
  13. 13.
    Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PRS, et al. Pharmacist-led medication review in patients over 65: a randomised control trial in primary care. Age Ageing. 2001;30:205–11. doi: 10.1093/ageing/30.3.205.PubMedCrossRefGoogle Scholar
  14. 14.
    Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, et al. Clinical medication review by a pharmacists of elderly people living in care homes—randomised controlled trial. Age Ageing. 2006;35(6):586–91. doi: 10.1093/ageing/afl075.PubMedCrossRefGoogle Scholar
  15. 15.
    Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ. 2005;330(7486):293–7. doi: 10.1136/bmj.38338.674583.AE.PubMedCrossRefGoogle Scholar
  16. 16.
    Holland R, Smith R, Harvey I. Where now for pharmacist led medication review? J Epidemiol Community Health. 2006;60(2):92–3. doi: 10.1136/jech.2005.035188.PubMedCrossRefGoogle Scholar
  17. 17.
    Salter C, Holland R, Harvey I, Henwood K. “I haven’t even phoned my doctor yet.” The advice giving role of the pharmacist during consultations for medication review with patients aged 80 or more: qualitative discourse analysis. BMJ. 2007;334(7603):1101–8. doi: 10.1136/bmj.39171.577106.55.PubMedCrossRefGoogle Scholar
  18. 18.
    Stewart D, George J, Bond C, Cunningham S, Diack L, McCaig D. Evaluating supplementary prescribing by pharmacists in Scotland. Report submitted to NHS Education for Scotland, 2007.Google Scholar
  19. 19.
    Baker R. Development of a questionnaire to assess patients’ satisfaction with consultations in general practice. Br J Gen Pract. 1990;40:487–90.PubMedGoogle Scholar
  20. 20.
    DeVellis RF. Scale development: theory and applications. California: Sage Publications; 1991.Google Scholar
  21. 21.
    While AE, Biggs KS. Benefits and challenges of nurse prescribing. J Adv Nurs. 2004;45(6):559–67. doi: 10.1046/j.1365-2648.2003.02948.x.PubMedCrossRefGoogle Scholar
  22. 22.
    Outline curriculum for training programmes to prepare pharmacist supplementary prescribers. Accessed 21 July 2006.
  23. 23.
    National Office for Summative Assessment. Accessed 14 November 2007.

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Derek C. Stewart
    • 1
    Email author
  • Johnson George
    • 1
    • 2
  • Christine M. Bond
    • 3
  • I. T. Scott Cunningham
    • 1
  • H. Lesley Diack
    • 1
  • Dorothy J. McCaig
    • 1
  1. 1.School of PharmacyThe Robert Gordon UniversitySchoolhill, AberdeenScotland
  2. 2.Department of Pharmacy Practice, Victorian College of PharmacyMonash UniversityParkvilleAustralia
  3. 3.Centre of Academic Primary CareUniversity of AberdeenAberdeenScotland

Personalised recommendations